![]() |
市场调查报告书
商品编码
1954673
全球水凝胶敷料市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察及预测(2026-2034年)Hydrogel Dressing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球水凝胶敷料市场规模为 8.29亿美元,预计将从2026年的8.7007亿美元成长至2034年的13.7179亿美元,预测期内(2026-2034年)年复合(CAGR)成长率为 5.90%。北美地区将在2025年占据 40.00%的市场占有率,这主要得益于慢性伤口盛行率的上升和强劲的医疗保健支出。
水凝胶敷料由约 90%的水和不溶性亲水性聚合物组成,可营造湿润温暖的环境,促进清创自溶解,加速伤口癒合。这些敷料广泛用于治疗糖尿病足溃疡、压疮、静脉性腿部溃疡、烧伤、手术伤口等。根据《美国医学会杂誌》(2023年 11月)报导,美国每年约有 160万人患有糖尿病足溃疡,全球每年约有 1860万人患有糖尿病足溃疡,这大幅推动了产品需求。
2020年,新冠肺炎疫情对市场造成了负面影响,导致患者就诊量减少,伤口护理部门也暂时关闭。然而,随着医疗服务的重新开放,2021年和2022年的收入有所恢復,市场成长也趋于正常。
市场动态
市场驱动因素
慢性及急性伤口盛行率上升
糖尿病足溃疡、压疮和手术部位感染(SSI)在全球日益严重的负担是推动市场成长的主要因素。手术伤口是造成医疗死亡率和医疗成本的重要因素。感染率的上升和癒合时间的延长推动对先进伤口护理解决方案(包括水凝胶敷料)的需求。
水凝胶敷料的优点
水凝胶敷料能够维持伤口湿润环境,促进组织再生,并透过自溶作用清除坏死组织。它们可以与局部用药联合使用,适用于多种类型的伤口。这些优势提升医生对该产品在医疗机构和家庭护理中的偏好度和产品采用率。
市场趋势
新型水凝胶研发投入增加
目前的研发重点是利用植物萃取物、动物组织和细胞外基质等天然资源开发创新水凝胶配方。各公司投资临床试验,以推出先进的水凝胶产品。例如,Remedol Biomed 进行一项基于促红血球生成素的水凝胶治疗糖尿病足溃疡的试验。
3D 列印和奈米技术等技术推动具有增强抗菌和再生性能的先进水凝胶敷料的开发,预计这将推动市场的长期成长。
限制因子
治疗成本上升及保险覆盖范围有限
慢性伤口护理的高昂成本仍然是一个重大障碍。例如,英国国家医疗服务体系(NHS)每年在伤口管理方面的支出约为 64.8亿美元。有限的偿付政策和高昂的自付费用阻碍了产品的普及,尤其是在发展中国家。这些财务挑战可能会限制预测期内的市场扩张。
依产品划分
市场依产品可分为非晶态敷料、浸渍敷料和片状敷料。
由于其卓越的癒合效率和易用性,非晶态敷料预计将在2026年占据 61.87%的市场占有率,成为市场主导。这些敷料广泛用于治疗溃疡和慢性伤口。
由于对 Aquacyte 水凝胶和 Solocyte 等产品的需求不断成长,预计浸渍敷料将实现温和成长。近年来,片状敷料的市场占有率显着成长,这得益于人们对维持伤口水分平衡的护理方案的日益重视。
依材料划分
依材料划分,市场可分为天然材料、合成材料及半合成材料。
合成材料细分市场预计将在2026年占据53.50%的市场占有率,这主要得益于以聚乙二醇和聚丙烯酸为原料的有效配方。这些材料能够创造最佳的伤口癒合环境。由于人们对生物基材料的偏好日益成长,天然材料领域预计将以更快的速度成长。
依应用领域划分
依应用领域划分,市场可分为糖尿病足溃疡、压疮、静脉性腿部溃疡、烧伤和其他。
其他领域(包括手术伤口和创伤性伤口)在2024年占据最大占有率,这主要受全球手术部位感染(SSI)发病率上升的推动。同时,受糖尿病患者数量增加和癒合时间延长的推动,预计糖尿病足溃疡领域在2026年将占据25.43%的市场占有率。预计到2034年,静脉性腿部溃疡和压疮的市场占有率将保持稳定成长。
依最终使用者划分
该市场依最终用户分为医院和诊所、家庭医疗保健和其他。
预计到2026年,医院和诊所将占据市场主导地位,市场占有率达 61.35%,这主要得益于患者数量众多和更优厚的偿付机制。家庭医疗保健预计将实现最快成长,这主要得益于人口老化和人们对居家伤口护理的偏好。
北美
到2025年,北美市场规模达到 3.3143亿美元,由于慢性伤口的高发病率和强劲的医疗保健投资,北美将继续保持领先地位。预计2026年,美国市场规模将达到3.102亿美元。
欧洲
由于成本削减措施和伤口管理方案的改进,欧洲将占据第二大市场占有率。预计2026年,德国市场规模将达到9,600万美元,英国市场规模将达4,950万美元。
亚太地区
预计亚太地区将实现最快成长。预计到2026年,中国市场规模将达到4,570万美元,印度为3,740万美元,日本为2,930万美元,主要得益于糖尿病患者数量众多以及人们健康意识的提高。
随着医疗保健服务的改善,预计拉丁美洲以及中东和非洲地区将稳步成长。
The global hydrogel dressing market size was valued at USD 829.0 million in 2025 and is projected to grow from USD 870.07 million in 2026 to USD 1,371.79 million by 2034, registering a CAGR of 5.90% during the forecast period (2026-2034). North America dominated the market with a 40.00% share in 2025, supported by rising chronic wound prevalence and strong healthcare spending.
Hydrogel dressings consist of nearly 90% water combined with insoluble hydrophilic polymers, creating a moist and warm environment that promotes autolytic debridement and accelerates wound healing. These dressings are widely used for diabetic foot ulcers, pressure ulcers, venous leg ulcers, burns, and surgical wounds. According to the Journal of the American Medical Association (November 2023), diabetic foot ulcers affect around 1.6 million individuals annually in the U.S. and 18.6 million globally, significantly driving product demand.
The COVID-19 pandemic negatively impacted the market in 2020 due to reduced patient visits and temporary closure of wound care departments. However, revenues recovered in 2021 and 2022 as healthcare services resumed, normalizing market growth.
Market Dynamics
Market Drivers
Rising Prevalence of Chronic and Acute Wounds
The growing global burden of diabetic foot ulcers, pressure injuries, and surgical site infections (SSI) is a key growth driver. Surgical wounds contribute significantly to healthcare mortality and costs. Increasing infection rates and prolonged healing durations have led to higher demand for advanced wound care solutions, including hydrogel dressings.
Advantages of Hydrogel Dressings
Hydrogel dressings maintain moisture, support tissue regeneration, and remove necrotic tissue through autolysis. They can be used with topical medications and are suitable for multiple wound types. These benefits have increased physician preference and product adoption across hospitals and homecare settings.
Market Trends
Increasing R&D on Novel Hydrogels
Ongoing research focuses on developing innovative hydrogel formulations using natural sources such as plant extracts, animal tissues, and extracellular matrices. Companies are investing in clinical trials to introduce advanced hydrogel products. For example, Remedor Biomed Ltd. is conducting trials on erythropoietin-based hydrogels for diabetic foot ulcers.
Technologies such as 3D printing and nanotechnology are enabling the development of advanced hydrogel dressings with enhanced antimicrobial and regenerative properties, which are expected to boost long-term market growth.
Restraining Factors
High Treatment Costs and Limited Reimbursement
The high cost of chronic wound care remains a major barrier. For example, the NHS spends approximately USD 6.48 billion annually on wound management. Limited reimbursement policies and high out-of-pocket expenses restrict product adoption, particularly in developing countries. These financial challenges may limit market expansion during the forecast period.
By Product
The market is segmented into amorphous, impregnated, and sheet dressings.
The amorphous segment dominated in 2026 with a 61.87% share, owing to its superior healing efficiency and ease of application. These dressings are widely preferred for treating ulcers and chronic wounds.
Impregnated dressings are projected to grow moderately due to increasing demand for products such as AquaSite Hydrogel and SOLOSITE. Sheet dressings accounted for a considerable share in recent years, supported by rising awareness of moisture-balancing wound care solutions.
By Material
Based on material, the market is divided into natural, synthetic, and semi-synthetic.
The synthetic segment led the market in 2026 with a 53.50% share, driven by effective formulations made from polyethylene glycol and polyacrylic acid. These materials create optimal wound-healing environments. The natural segment is expected to grow at a faster pace due to increasing preference for biologically derived materials.
By Application
The market is categorized into diabetic foot ulcers, pressure ulcers, venous leg ulcers, burn injuries, and others.
The others segment (including surgical and traumatic wounds) dominated in 2024, supported by rising SSI incidence globally. Meanwhile, the diabetic foot ulcer segment accounted for 25.43% share in 2026, driven by the growing diabetic population and prolonged healing requirements. Venous leg ulcers and pressure ulcers are expected to grow steadily through 2034.
By End-user
The market is segmented into hospitals & clinics, homecare settings, and others.
The hospitals & clinics segment dominated in 2026 with a 61.35% share, due to high patient inflow and better reimbursement structures. Homecare settings are anticipated to witness the fastest growth, supported by rising geriatric populations and preference for at-home wound management.
North America
North America accounted for USD 331.43 million in 2025, maintaining leadership due to high chronic wound prevalence and strong healthcare investments. The U.S. market is projected to reach USD 310.2 million in 2026.
Europe
Europe holds the second-largest share, supported by cost-reduction initiatives and improved wound management programs. The Germany market is projected at USD 96 million in 2026, while the UK market is projected at USD 49.5 million in 2026.
Asia Pacific
Asia Pacific is expected to witness the fastest growth. The China market is projected at USD 45.7 million in 2026, India at USD 37.4 million, and Japan at USD 29.3 million, driven by a large diabetic population and increasing healthcare awareness.
Latin America and the Middle East & Africa are expected to grow steadily with improving healthcare access.
Competitive Landscape
The market is semi-consolidated with key players including 3M, Smith+Nephew, ConvaTec Group, Coloplast A/S, Integra LifeSciences, B. Braun SE, and Essity Aktiebolag. Companies focus on partnerships, acquisitions, and product innovation to expand global presence.
Notable developments include:
Conclusion
The global hydrogel dressing market is projected to grow steadily from USD 829.0 million in 2025 to USD 870.07 million in 2026, reaching USD 1,371.79 million by 2034, at a CAGR of 5.90%. Rising chronic wound prevalence, technological advancements, and expanding geriatric populations are key growth drivers. While high treatment costs and reimbursement limitations pose challenges, continuous innovation and growing healthcare investments are expected to sustain long-term market expansion worldwide.
Segmentation By Product
By Material
By Application
By End-user
By Region